[{"AccountsAndOtherReceivablesNetCurrent_0_FY_USD":172000.0,"OperatingLeaseRightOfUseAsset_0_FY_USD":2970000.0,"OperatingLeasePayments_4_FY_USD":1800000.0,"OperatingLeaseLiabilityNoncurrent_0_FY_USD":1296000.0,"OperatingLeaseLiabilityCurrent_0_FY_USD":1746000.0,"OperatingLeaseLiability_0_FY_USD":3042000.0,"OperatingLeaseCost_4_FY_USD":1900000.0,"OperatingIncomeLoss_4_FY_USD":-71243000.0,"NumberOfOperatingSegments_4_FY_segment":1.0,"NetIncomeLossAvailableToCommonStockholdersBasic_4_FY_USD":-70511000.0,"NetCashProvidedByUsedInOperatingActivities_4_FY_USD":-60909000.0,"NetCashProvidedByUsedInInvestingActivities_4_FY_USD":-216156000.0,"NetCashProvidedByUsedInFinancingActivities_4_FY_USD":272372000.0,"MarketableSecuritiesCurrent_0_FY_USD":369107000.0,"OperatingLeaseWeightedAverageDiscountRatePercent_0_FY_pure":0.1,"LiabilitiesCurrent_0_FY_USD":16528000.0,"Liabilities_0_FY_USD":25178000.0,"LesseeOperatingLeaseLiabilityUndiscountedExcessAmount_0_FY_USD":270000.0,"LesseeOperatingLeaseLiabilityPaymentsDueYearTwo_0_FY_USD":1269000.0,"LesseeOperatingLeaseLiabilityPaymentsDueYearThree_0_FY_USD":73000.0,"LesseeOperatingLeaseLiabilityPaymentsDueNextTwelveMonths_0_FY_USD":1970000.0,"LesseeOperatingLeaseLiabilityPaymentsDue_0_FY_USD":3312000.0,"InvestmentsAndCash_0_FY_USD":408300000.0,"InterestReceivable_0_FY_USD":1300000.0,"InterestAndOtherIncome_4_FY_USD":505000.0,"IntangibleAssetsNetExcludingGoodwill_0_FY_USD":27190000.0,"IndefiniteLivedIntangibleAssetsExcludingGoodwill_0_FY_USD":27200000.0,"IncreaseDecreaseInPrepaidDeferredExpenseAndOtherAssets_4_FY_USD":1871000.0,"IncreaseDecreaseInOtherOperatingLiabilities_4_FY_USD":-4405000.0,"LiabilitiesAndStockholdersEquity_0_FY_USD":444654000.0,"IncreaseDecreaseInOtherOperatingAssets_4_FY_USD":5000.0,"OtherAccruedLiabilitiesCurrent_0_FY_USD":283000.0,"OtherComprehensiveIncomeUnrealizedHoldingGainLossOnSecuritiesArisingDuringPeriodNetOfTax_4_FY_USD":-695000.0,"VariableLeaseCost_4_FY_USD":700000.0,"ValuationAllowanceDeferredTaxAssetChangeInAmount_4_FY_USD":-11158000.0,"StockIssuedDuringPeriodValueNewIssues_4_FY_USD":269893000.0,"StockIssuedDuringPeriodValueEmployeeStockPurchasePlan_4_FY_USD":2479000.0,"StockholdersEquity_0_FY_USD":419476000.0,"StateAndLocalIncomeTaxExpenseBenefitContinuingOperations_4_FY_USD":-7082000.0,"ShareBasedCompensation_4_FY_USD":8953000.0,"RevenueFromContractWithCustomerExcludingAssessedTax_4_FY_USD":4651000.0,"RetainedEarningsAccumulatedDeficit_0_FY_USD":-1143607000.0,"ResearchAndDevelopmentExpense_4_FY_USD":53311000.0,"ReclassificationFromAccumulatedOtherComprehensiveIncomeCurrentPeriodNetOfTax_4_FY_USD":0.0,"PropertyPlantAndEquipmentNet_0_FY_USD":3551000.0,"PropertyPlantAndEquipmentGross_0_FY_USD":24677000.0,"OtherAssetsNoncurrent_0_FY_USD":104000.0,"ProceedsFromStockPlans_4_FY_USD":2479000.0,"ProceedsFromSaleAndMaturityOfMarketableSecurities_4_FY_USD":174947000.0,"ProceedsFromIssuanceOfCommonStock_4_FY_USD":269893000.0,"PrepaidExpenseAndOtherAssetsCurrent_0_FY_USD":2417000.0,"PreferredStockSharesOutstanding_0_FY_shares":0.0,"PreferredStockSharesIssued_0_FY_shares":0.0,"PreferredStockSharesAuthorized_0_FY_shares":3000000.0,"PreferredStockParOrStatedValuePerShare_0_FY_USD":0.01,"PaymentsToAcquirePropertyPlantAndEquipment_4_FY_USD":1249000.0,"PaymentsToAcquireMarketableSecurities_4_FY_USD":389881000.0,"OtherThanTemporaryImpairmentCreditLossesRecognizedInEarningsCreditLossesOnDebtSecuritiesHeld_0_FY_USD":0.0,"OtherLiabilitiesNoncurrent_0_FY_USD":7354000.0,"OtherLiabilitiesCurrent_0_FY_USD":1554000.0,"OtherLiabilities_0_FY_USD":8908000.0,"ProceedsFromSaleOfProductiveAssets_4_FY_USD":27000.0,"IncreaseDecreaseInAccountsPayableAndAccruedLiabilities_4_FY_USD":3653000.0,"IncreaseDecreaseInAccountsAndOtherReceivables_4_FY_USD":-1574000.0,"IncomeTaxReconciliationTaxCreditsResearch_4_FY_USD":2422000.0,"ConstructionInProgressExpendituresIncurredButNotYetPaid_4_FY_USD":289000.0,"ComprehensiveIncomeNetOfTax_4_FY_USD":-71206000.0,"CommonStockValue_0_FY_USD":47000.0,"CommonStockSharesOutstanding_0_FY_shares":46730198.0,"CommonStockSharesIssued_0_FY_shares":46730198.0,"CommonStockSharesAuthorized_0_FY_shares":297000000.0,"CommonStockParOrStatedValuePerShare_0_FY_USD":0.001,"CommitmentsAndContingencies_0_FY_USD":null,"CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect_4_FY_USD":-4693000.0,"CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents_0_FY_USD":39143000.0,"CashAndCashEquivalentsAtCarryingValue_0_FY_USD":39143000.0,"BusinessCombinationContingentConsiderationLiability_0_FY_USD":6862000.0,"BusinessCombinationContingentConsiderationArrangementsChangeInAmountOfContingentConsiderationAsset1_4_FY_USD":1405000.0,"ContractWithCustomerAssetNet_0_FY_USD":0.0,"AvailableForSaleDebtSecuritiesAmortizedCostBasis_0_FY_USD":369809000.0,"AssetsCurrent_0_FY_USD":410839000.0,"Assets_0_FY_USD":444654000.0,"AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount_4_FY_shares":4077667.0,"AllocatedShareBasedCompensationExpense_4_FY_USD":8953000.0,"AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue_4_FY_USD":8953000.0,"AdditionalPaidInCapitalCommonStock_0_FY_USD":1561142000.0,"AccumulatedOtherComprehensiveIncomeLossNetOfTax_0_FY_USD":1894000.0,"AccumulatedOtherComprehensiveIncomeLossForeignCurrencyTranslationAdjustmentNetOfTax_0_FY_USD":2600000.0,"AccumulatedDepreciationDepletionAndAmortizationPropertyPlantAndEquipment_0_FY_USD":21126000.0,"AccruedProfessionalFeesCurrent_0_FY_USD":878000.0,"AccruedLiabilitiesCurrent_0_FY_USD":12000000.0,"AccretionAmortizationOfDiscountsAndPremiumsInvestments_4_FY_USD":3209000.0,"AccountsPayableCurrent_0_FY_USD":1228000.0,"AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedLossBeforeTax_0_FY_USD":702000.0,"ContractWithCustomerLiability_0_FY_USD":433000.0,"ContractWithCustomerLiabilityRevenueRecognized_4_FY_USD":3400000.0,"CostOfGoodsAndServicesSold_4_FY_USD":100000.0,"IncomeTaxReconciliationTaxContingenciesOther_4_FY_USD":-295000.0,"IncomeTaxReconciliationStateAndLocalIncomeTaxes_4_FY_USD":-7082000.0,"IncomeTaxReconciliationOtherAdjustments_4_FY_USD":-941000.0,"IncomeTaxReconciliationIncomeTaxExpenseBenefitAtFederalStatutoryIncomeTaxRate_4_FY_USD":-14855000.0,"IncomeTaxReconciliationChangeInDeferredTaxAssetsValuationAllowance_4_FY_USD":11158000.0,"IncomeTaxExpenseBenefit_4_FY_USD":-227000.0,"IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest_4_FY_USD":-70738000.0,"ImpairmentOfIntangibleAssetsIndefinitelivedExcludingGoodwill_4_FY_USD":3500000.0,"GeneralAndAdministrativeExpense_4_FY_USD":20488000.0,"GainLossOnSaleOfPropertyPlantEquipment_4_FY_USD":24000.0,"FederalIncomeTaxExpenseBenefitContinuingOperations_4_FY_USD":-18513000.0,"EmployeeRelatedLiabilitiesCurrent_0_FY_USD":7968000.0,"EarningsPerShareDiluted_4_FY_USD":-1.64,"EarningsPerShareBasic_4_FY_USD":-1.64,"DepreciationDepletionAndAmortization_4_FY_USD":3068000.0,"DefinedContributionPlanMaximumAnnualContributionsPerEmployeePercent_4_FY_pure":0.6,"DefinedContributionPlanEmployerMatchingContributionPercentOfMatch_4_FY_pure":0.5,"DefinedContributionPlanEmployerMatchingContributionPercent_4_FY_pure":0.04,"DefinedContributionPlanCostRecognized_4_FY_USD":400000.0,"DeferredTaxLiabilities_0_FY_USD":1613000.0,"DeferredTaxAssetsValuationAllowance_0_FY_USD":302540000.0,"DeferredTaxAssetsTaxDeferredExpenseOther_0_FY_USD":370000.0,"DeferredTaxAssetsTaxDeferredExpenseCompensationAndBenefitsShareBasedCompensationCost_0_FY_USD":14719000.0,"DeferredTaxAssetsTaxDeferredExpense_0_FY_USD":59753000.0,"DeferredTaxAssetsTaxCreditCarryforwards_0_FY_USD":47927000.0,"DeferredTaxAssetsPropertyPlantAndEquipment_0_FY_USD":1287000.0,"DeferredTaxAssetsOperatingLossCarryforwards_0_FY_USD":183711000.0,"DeferredTaxAssetsGross_0_FY_USD":307767000.0,"CostsAndExpenses_4_FY_USD":75894000.0,"WeightedAverageNumberOfDilutedSharesOutstanding_4_FY_shares":42870.0,"WeightedAverageNumberOfSharesOutstandingBasic_4_FY_shares":42870.0,"Ticker":"CLDX","CIK":"744218","name":"CELLDEX THERAPEUTICS, INC.","OfficialName":"Celldex Therapeutics Inc.","form":"10-K","period":"20211231","fy":"2021.0","fp":"FY","qtrs":"0","uom":"USD","footnote":"nan","Market Cap":"1601609341.0","Country":"United States","Sector":"Health Care","Industry":"Biotechnology: In Vitro & In Vivo Diagnostic Substances","Market":"NASDAQ","SP500":"nan","filed":"20220228"}]